These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 28390192)
1. Runt-Related Transcription Factor 2 (Runx2) Is Responsible for Galectin-3 Overexpression in Human Thyroid Carcinoma. Kaptan E; Sancar Bas S; Sancakli A; Aktas HG; Bayrak BB; Yanardag R; Bolkent S J Cell Biochem; 2017 Nov; 118(11):3911-3919. PubMed ID: 28390192 [TBL] [Abstract][Full Text] [Related]
2. Transcription factor Runx2 is a regulator of epithelial-mesenchymal transition and invasion in thyroid carcinomas. Niu DF; Kondo T; Nakazawa T; Oishi N; Kawasaki T; Mochizuki K; Yamane T; Katoh R Lab Invest; 2012 Aug; 92(8):1181-90. PubMed ID: 22641097 [TBL] [Abstract][Full Text] [Related]
3. Expression and function of Cbfa-1/Runx2 in thyroid papillary carcinoma cells. Endo T; Ohta K; Kobayashi T J Clin Endocrinol Metab; 2008 Jun; 93(6):2409-12. PubMed ID: 18381576 [TBL] [Abstract][Full Text] [Related]
4. Galectin-1 is a diagnostic marker involved in thyroid cancer progression. Arcolia V; Journe F; Wattier A; Leteurtre E; Renaud F; Gabius HJ; Remmelink M; Decaestecker C; Rodriguez A; Boutry S; Laurent S; Saussez S Int J Oncol; 2017 Sep; 51(3):760-770. PubMed ID: 28677745 [TBL] [Abstract][Full Text] [Related]
5. Galectin-3 promotes chronic activation of K-Ras and differentiation block in malignant thyroid carcinomas. Levy R; Grafi-Cohen M; Kraiem Z; Kloog Y Mol Cancer Ther; 2010 Aug; 9(8):2208-19. PubMed ID: 20682656 [TBL] [Abstract][Full Text] [Related]
6. The expression profiles of the galectin gene family in primary and metastatic papillary thyroid carcinoma with particular emphasis on galectin-1 and galectin-3 expression. Salajegheh A; Dolan-Evans E; Sullivan E; Irani S; Rahman MA; Vosgha H; Gopalan V; Smith RA; Lam AK Exp Mol Pathol; 2014 Apr; 96(2):212-8. PubMed ID: 24530443 [TBL] [Abstract][Full Text] [Related]
7. Changes in the expression pattern of apoptotic molecules (galectin-3, Bcl-2, Bax, survivin) during progression of thyroid malignancy and their clinical significance. Selemetjev SA; Savin SB; Paunovic IR; Tatic SB; Cvejic D Wien Klin Wochenschr; 2015 May; 127(9-10):337-44. PubMed ID: 25471003 [TBL] [Abstract][Full Text] [Related]
8. Expression of Galectin-3 and Galectin-7 in thyroid malignancy as potential diagnostic indicators. Than TH; Swethadri GK; Wong J; Ahmad T; Jamil D; Maganlal RK; Hamdi MM; Abdullah MS Singapore Med J; 2008 Apr; 49(4):333-8. PubMed ID: 18418527 [TBL] [Abstract][Full Text] [Related]
9. Activating transcription factor-1-mediated hepatocyte growth factor-induced down-regulation of thrombospondin-1 expression leads to thyroid cancer cell invasion. Ghoneim C; Soula-Rothhut M; Blanchevoye C; Martiny L; Antonicelli F; Rothhut B J Biol Chem; 2007 May; 282(21):15490-7. PubMed ID: 17409099 [TBL] [Abstract][Full Text] [Related]
10. Runx2 mRNA expression in the tissue, serum, and circulating non-hematopoietic cells of patients with thyroid cancer. Dalle Carbonare L; Frigo A; Francia G; Davì MV; Donatelli L; Stranieri C; Brazzarola P; Zatelli MC; Menestrina F; Valenti MT J Clin Endocrinol Metab; 2012 Jul; 97(7):E1249-56. PubMed ID: 22511796 [TBL] [Abstract][Full Text] [Related]
11. Thyroid Hormone Receptor-β (TRβ) Mediates Runt-Related Transcription Factor 2 (Runx2) Expression in Thyroid Cancer Cells: A Novel Signaling Pathway in Thyroid Cancer. Carr FE; Tai PW; Barnum MS; Gillis NE; Evans KG; Taber TH; White JH; Tomczak JA; Jaworski DM; Zaidi SK; Lian JB; Stein JL; Stein GS Endocrinology; 2016 Aug; 157(8):3278-92. PubMed ID: 27253998 [TBL] [Abstract][Full Text] [Related]
12. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer. Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909 [TBL] [Abstract][Full Text] [Related]
13. Runx2 is expressed in human glioma cells and mediates the expression of galectin-3. Vladimirova V; Waha A; Lückerath K; Pesheva P; Probstmeier R J Neurosci Res; 2008 Aug; 86(11):2450-61. PubMed ID: 18438928 [TBL] [Abstract][Full Text] [Related]
14. Differential expression of PIWIL2 in papillary thyroid cancers. Erdogdu IH; Yumrutas O; Ozgur Cevik M; Bozgeyik I; Erdogdu M; Inan HM; Bagis H Gene; 2018 Apr; 649():8-13. PubMed ID: 29369786 [TBL] [Abstract][Full Text] [Related]
15. TWIST1/miR-584/TUSC2 pathway induces resistance to apoptosis in thyroid cancer cells. Orlandella FM; Di Maro G; Ugolini C; Basolo F; Salvatore G Oncotarget; 2016 Oct; 7(43):70575-70588. PubMed ID: 27661106 [TBL] [Abstract][Full Text] [Related]
16. [Usefulness of galectin-3 expression in the clinical behavior of differentiated thyroid carcinoma]. López Mondéjar P; Picó A; Seguí J; López Maciá A Med Clin (Barc); 2008 Feb; 130(5):161-4. PubMed ID: 18341829 [TBL] [Abstract][Full Text] [Related]
17. [Expression of TTF-1 in thyroid tumors originating from follicular epithelium and its correlation with expression of RET, galectin-3 and mucin-1 genes]. Chen Y; Zhu M; Zhou X; Lin W; Ni C; Li F; Zhang S; Gong Z Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(4):257-61. PubMed ID: 11953175 [TBL] [Abstract][Full Text] [Related]
18. Methylation of DACT2 promotes papillary thyroid cancer metastasis by activating Wnt signaling. Zhao Z; Herman JG; Brock MV; Sheng J; Zhang M; Liu B; Guo M PLoS One; 2014; 9(11):e112336. PubMed ID: 25375359 [TBL] [Abstract][Full Text] [Related]
19. Tumor suppressor role of the CL2/DRO1/CCDC80 gene in thyroid carcinogenesis. Ferraro A; Schepis F; Leone V; Federico A; Borbone E; Pallante P; Berlingieri MT; Chiappetta G; Monaco M; Palmieri D; Chiariotti L; Santoro M; Fusco A J Clin Endocrinol Metab; 2013 Jul; 98(7):2834-43. PubMed ID: 23666966 [TBL] [Abstract][Full Text] [Related]
20. Identification of targets of Twist1 transcription factor in thyroid cancer cells. Di Maro G; Orlandella FM; Bencivenga TC; Salerno P; Ugolini C; Basolo F; Maestro R; Salvatore G J Clin Endocrinol Metab; 2014 Sep; 99(9):E1617-26. PubMed ID: 24848707 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]